Sydney IVF: Stem Cell Research Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies

This case examines the strategy implementation and risk management decisions at Sydney IVF, a research-based in vitro fertilization and stem cell company based in Australia. Drs. Robert Jansen and Jock Anderson, who co-founded Sydney IVF in 1986, developed new technologies which they leveraged to carve a leadership function in the inherently dangerous artificial fertilization company. As the firm grew, its executives grappled with managing the political, ethical and business risks associated with the controversial lab-based fertility subject, instituting classy safeguards including an independent ethics committee and a "whistle blower" system for employees concerned with the firm's practices.

In less than two decades, Sydney IVF grew to over 200 from only four employees, expanded globally, and extended its services to include prenatal screening for genetic diseases and DNA tests to ascertain paternity and lineage. Moreover, the firm launched a wholly-owned subsidiary company, the Stem Cell Business. CEO Robert Jansen expected to grow the Stem Cell Business, but faced many challenges, including the significant ethical hazards, challenging regulatory environment, and uncertain future of the stem cell niche. The case describes how Jansen safeguards against risk without stifling the innovative spirit essential to commercialize stem cells.

Sydney IVF Stem Cell Research case study solution

PUBLICATION DATE: January 26, 2009 PRODUCT #: 109017-HCB-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION